The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...

Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...

Mpox remains an international public health emergency, the World Health Organization (WHO) said on Feb 27 (2025). This was after the international health agency decided the epidemic still merits the ...

Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

Arua City plans to increase sensitization in areas along the border of Uganda and the Democratic Republic of Congo (DRC) ...

The Foreign Office has put UK holidaymakers heading out of the European Union on alert over the need to pass a Mpox screening ...

Dr. Alex Isakov offers updates and insights for EMS professionals on navigating the infectious disease landscape ...

HEALTH Minister Jenista Mhagama has affirmed the presence of the Mpox contagious disease in the country, with two individuals ...

Colorized transmission electron micrograph of immature mpox virus particles (blue with red viral envelope) found within an infected VERO E6 cell (yellow), cultured in the laboratory. Image captured at ...

Nurses are administering medicine to Mpox patients at a tent in Kabare, Democratic Republic of the Congo, as the area ...

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

MITI MURHESA, Congo — Hospitals across eastern Congo that were once at the forefront of the country’s response to the mpox outbreak are facing a setback in detecting the disease and offering ...